Psilocybin for Depression Win; 1 in 10 Kids Have ADHD; Loneliness in Middle Age

(MedPage Today) -- The FDA granted CYB003 -- an investigational depression treatment that acts as a deuterated psilocybin analog -- a breakthrough therapy designation after patients achieved an average 22-point symptom reduction in Montgomery...
Source: MedPage Today Psychiatry - Category: Psychiatry Source Type: news